Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Sterility Testing Method Transfer to QC – V 2.0

Posted on By

Analytical Method Development: SOP for Sterility Testing Method Transfer to QC – V 2.0

Standard Operating Procedure for Transfer of Sterility Testing Method to Quality Control Department


Department Analytical Method Development
SOP No. SOP/AMD/230/2025
Supersedes SOP/AMD/230/2022
Page No. Page 1 of 14
Issue Date 21/05/2025
Effective Date 23/05/2025
Review Date 21/05/2026

1. Purpose

To define a standardized procedure for the successful transfer of sterility testing methodology from the Analytical Method Development (AMD) department to the Quality

Control (QC) laboratory for routine execution in compliance with GMP and pharmacopeial standards.

2. Scope

This SOP is applicable to all validated sterility testing methods developed for sterile finished products or components in the AMD department intended to be executed routinely by the QC Microbiology laboratory.

3. Responsibilities

  • AMD Microbiologist: Prepares the transfer protocol and shares validated method details with QC.
  • QC Analyst: Executes transferred method under supervision during demonstration runs.
  • AMD Supervisor: Reviews readiness and issues Transfer Completion Report.
  • QA Executive: Ensures traceability and regulatory compliance of transfer documentation.
See also  Analytical Method Development: SOP for XRPD Method for Polymorph Characterization - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for ensuring complete and successful transfer of sterility methods to QC, supported by comprehensive documentation, training, and verification.

5. Procedure

5.1 Preparation of Method Transfer Protocol

  1. Include the following in the protocol:
    • Method principle and objective
    • Sample and media requirements
    • Test organisms and challenge conditions
    • Acceptance criteria
  2. Obtain approval from AMD, QC, and QA before initiation.

5.2 Method Demonstration

  1. AMD personnel demonstrate:
    • Membrane filtration or direct inoculation technique
    • Use of isolator or sterility testing isolator/glove box
    • Positive control handling
  2. QC personnel perform at least three supervised runs using:
    • Positive controls (e.g., B. subtilis, C. albicans)
    • Negative controls (media blanks)
See also  Analytical Method Development: Related Substances Method Development by HPLC - V 2.0

5.3 Comparative Evaluation

  1. Compare QC results with AMD historical performance using:
    • Contamination rate
    • Incubation uniformity
    • Recovery confirmation
  2. Record findings in Annexure-2.

5.4 Documentation and Completion

  1. Prepare Method Transfer Report including:
    • Training attendance records
    • Protocol compliance summary
    • Any deviations or observations
  2. Obtain final QA approval and file all records as per GMP retention policy.

6. Abbreviations

  • AMD: Analytical Method Development
  • QC: Quality Control
  • QA: Quality Assurance
  • CFU: Colony Forming Units
  • SOP: Standard Operating Procedure

7. Documents

  1. Sterility Method Transfer Protocol – Annexure-1
  2. Comparative Test Data Sheet – Annexure-2
  3. Method Transfer Completion Report – Annexure-3

8. References

  • USP <71> Sterility Tests
  • Ph. Eur. 2.6.1 Sterility
  • ICH Q4B Annex 8 – Sterility Test
  • WHO Technical Report Series 961

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Dr. Meenal Raut Yash Mehra Sunita Reddy
Designation Microbiologist QA Reviewer Head – AMD
Department Analytical Method Development QA Analytical Method Development

11. Annexures

Annexure-1: Sterility Method Transfer Protocol

Method Type Organism Panel Incubation Temp Incubation Time
Membrane Filtration B. subtilis, C. albicans 20–25°C / 30–35°C 14 Days

Annexure-2: Comparative Test Data

Test Run Contamination Rate (QC) Contamination Rate (AMD) Status
Run 1 0% 0% Acceptable

Annexure-3: Method Transfer Completion Report

The sterility testing method was successfully transferred to QC. All demonstration runs were completed without deviations. Recovery rates and contamination profiles matched AMD records. QC team trained and certified. Method is ready for routine implementation.

Revision History:

Revision Date Revision No. Details Reason Approved By
21/05/2025 2.0 Included criteria for method comparison and QA completion Annual Review and Tech Transfer Audit Sunita Reddy
12/05/2022 1.0 Initial SOP Release New SOP QA Head
See also  Analytical Method Development: Moisture Analysis Method for Hygroscopic APIs - V 2.0
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Gel Manufacturing: SOP for Cleaning Logs Documentation for Mixing Vessels – V 2.0
Next Post: Sterile Injectable Manufacturing: SOP for Cleaning Validation of High-Pressure Pumps – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version